Home
Storia in 2 fonti
Obesity drug semaglutide fails to slow Alzheimer's
There were initial hopes that the drug in weight loss jab Wegovy could slow progression of dementia.
- ·
cnbc.com
Novo Nordisk shares plunge 10% after Alzheimer's drug trial fails to hit key target
Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal.
- ·
bbc.com
Obesity drug semaglutide fails to slow Alzheimer's
There were initial hopes that the drug in weight loss jab Wegovy could slow progression of dementia.